Matglim PG 1mg/500mg/15mg Tablet SR
Marketer
JV Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Matglim PG 1mg/500mg/15mg Tablet SR
Combiflex-D, a triple-combination tablet (1mg/500mg/15mg SR), effectively manages blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, it enhances insulin efficiency, reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions. Always take it with food to minimize stomach discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. High doses risk hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is vital. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your doctor before use if you have kidney, liver, or heart issues, or are pregnant/breastfeeding. Kidney function tests are typically performed before commencing treatment. Limit alcohol consumption to lessen potential side effects.
Primary Ingredients of Matglim PG 1mg/500mg/15mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Matglim PG 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Matglim PG 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Matglim PG 1mg/500mg/15mg Sustained-Release tablet should be administered with a meal.
Common Side effects of Matglim PG 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Matglim PG 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Matglim PG 1mg/500mg/15mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this extended-release tablet with a meal.
How Matglim PG 1mg/500mg/15mg Tablet SR works:
Matglim PG 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ different actions to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Matglim PG 1mg/500mg/15mg SR tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Matglim PG 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The combined medication Matglim PG 1mg/500mg/15mg sustained-release tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Matglim PG 1mg/500mg/15mg SR tablets to individuals with kidney impairment; dosage modification may be necessary. Severe kidney disease contraindicates the use of Matglim PG 1mg/500mg/15mg SR tablets. Physician consultation is recommended. Close monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Matglim PG 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Matglim PG 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Matglim PG 1mg/500mg/15mg Tablet SR :
Should you forget a dose of Matglim PG 1mg/500mg/15mg Tablet SR, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Matglim PG 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently